Acute exercise and brain BACE 1 protein content: a time course study
نویسندگان
چکیده
منابع مشابه
Protein Flexibility in Virtual Screening: The BACE-1 Case Study
Simulating protein flexibility is a major issue in the docking-based drug-design process for which a single methodological solution does not exist. In our search of new anti-Alzheimer ligands, we were faced with the challenge of including receptor plasticity in a virtual screening campaign aimed at finding new β-secretase inhibitors. To this aim, we incorporated protein flexibility in our simul...
متن کاملTime course evaluation of protein synthesis and glucose uptake after acute resistance exercise in rats.
The temporal pattern for changes in rates of protein synthesis and glucose uptake after resistance exercise, especially relative to each other, is not known. Male Sprague-Dawley rats performed acute resistance exercise (n = 7) or remained sedentary (n = 7 per group), and the following were assessed in vivo 1, 3, 6, 12 and 24 h later: rates of protein synthesis, rates of glucose uptake, phosphat...
متن کاملProtein lipidation of BACE.
Our research has concentrated upon the protein lipid modification of BACE [beta-site amyloid precursor protein cleaving enzyme (beta-secretase)], of which very little is currently known. Lipidation influences the production of Abeta (amyloid beta-protein) by promoting the dimerization of BACE.
متن کاملTime course of activity in itch - related brain regions : A combined 1 MEG - fMRI study
Time course of activity in itch-related brain regions: A combined 1 MEG-fMRI study 2 3 Hideki Mochizuki , Koji Inui , Hiroki C. Tanabe , Lisa F. Akiyama , Naofumi 4 Otsuru , Koya Yamashiro , Akihiro Sasaki , Hiroki Nakata 7, , Norihiro Sadato 4 5 and Ryusuke Kakigi . 6 7 1 Department of Integrative Physiology, National Institute for Physiological Sciences, 8 Okazaki, Aichi, 444-8585, Japan 9 2 ...
متن کاملPotent and Selective BACE-1 Peptide Inhibitors Lower Brain Aβ Levels Mediated by Brain Shuttle Transport
Therapeutic approaches to fight Alzheimer's disease include anti-Amyloidβ (Aβ) antibodies and secretase inhibitors. However, the blood-brain barrier (BBB) limits the brain exposure of biologics and the chemical space for small molecules to be BBB permeable. The Brain Shuttle (BS) technology is capable of shuttling large molecules into the brain. This allows for new types of therapeutic modaliti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Physiological Reports
سال: 2019
ISSN: 2051-817X,2051-817X
DOI: 10.14814/phy2.14084